The 4G/4G plasminogen activator inhibitor-1 genotype is associated with frequent recurrence of acute otitis media

被引:14
|
作者
Emonts, Marieke
Wiertsema, Selma P.
Veenhoven, Reinier H.
Houwing-Duistermaat, Jeanine J.
Walraven, Vanessa
de Groot, Ronald
Hermans, Peter W. M.
Sanders, Elisabeth A. M.
机构
[1] Erasmus Univ, Med Ctr, Sophia Childrens Hosp, Dept Pediat, Rotterdam, Netherlands
[2] Univ Utrecht, Med Ctr, Dept Pediat Immunol, Utrecht, Netherlands
[3] Spaarne Hosp, Dept Pediat, Hoofddorp, Netherlands
[4] Leiden Univ, Med Ctr, Dept Med Stat, Leiden, Netherlands
[5] Radboud Univ Nijmegen, Med Ctr, Dept Pediat, Nijmegen, Netherlands
关键词
plasminogen activator inhibitor-1; polymorphism; otitis media;
D O I
10.1542/peds.2006-1390
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objectives. Plasminogen activator inhibitor-1 counterregulates cell migration, adhesion, and tissue repair. The PAI1 4G/5G promoter polymorphism has an effect on expression levels of PAI1. After a first acute otitis media episode, children are at increased risk for a next episode. Because the PAI1 4G allele is associated with higher plasminogen activator inhibitor-1 production and, hence, decreased tissue repair, we hypothesize that this allele may contribute to increased recurrence of acute otitis media. Patients and Methods. The PAI1 4G/5G polymorphism was genotyped in 348 Dutch children aged 1 to 7 years who were suffering from recurrent acute otitis media and participating in a randomized, controlled trial and 463 healthy control subjects, representative of the general population. Results. No significant difference in PAI1 genotype distribution between the whole acute otitis media group and control subjects was observed. However, children with the PAI1 4G/4G genotype had an increased risk of more frequent acute otitis media episodes compared with those who were homozygous for the 5G variant, also after correction for cofactors. This finding was attributable to children < 4 years of age. Conclusions. Our findings suggest that the PAI1 4G/4G genotype is associated with an increased risk for the otitis-prone condition, potentially because of impaired healing after a previous otitis media episode.
引用
收藏
页码:E317 / E323
页数:7
相关论文
共 50 条
  • [1] The 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene is associated with severe preeclampsia
    N. Yamada
    T. Arinami
    K. Yamakawa-Kobayashi
    H. Watanabe
    S. Sohda
    H. Hamada
    T. Kubo
    H. Hamaguchi
    Journal of Human Genetics, 2000, 45 : 138 - 141
  • [2] The 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene is associated with severe preeclampsia
    Yamada, N
    Arinami, T
    Yamakawa-Kobayashi, K
    Watanabe, H
    Sohda, S
    Hamada, H
    Kubo, T
    Hamaguchi, H
    JOURNAL OF HUMAN GENETICS, 2000, 45 (03) : 138 - 141
  • [3] 4 G/4G polymorphism of plasminogen activator inhibitor-1 gene increases the risk of diabetic nephropathy
    Xue, Cheng
    Nie, Wei
    Zhou, Chenchen
    Yu, Fei
    Wang, Dong-Mei
    Dai, Bing
    Mei, Chang-Lin
    RENAL FAILURE, 2014, 36 (03) : 332 - 338
  • [4] Plasminogen activator inhibitor-1 4G/5G polymorphism is associated with type 2 diabetes risk
    Zhao, Luqian
    Huang, Ping
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2013, 6 (08): : 632 - 640
  • [5] Promoter (4G/5G) plasminogen activator inhibitor-1 genotype in Pima Indians: Relationship to plasminogen activator inhibitor-1 levels and features of the insulin resistance syndrome
    McCormack, LJ
    Nagi, DK
    Stickland, MH
    Mansfield, MW
    MohamedAli, V
    Yudkin, JS
    Knowler, WC
    Grant, PJ
    DIABETOLOGIA, 1996, 39 (12) : 1512 - 1518
  • [6] Plasminogen activator inhibitor-1 4G/5G gene polymorphism in women with fetal loss
    Ghosh, Kanjaksha
    Shetty, Shrimati
    Vora, Sonal
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2009, 107 (02) : 159 - 160
  • [7] Plasminogen activator inhibitor-1 4G/5G polymorphism and susceptibility to endometriosis in the Italian population
    Gentilini, Davide
    Vigano, Paola
    Castaldi, Davide
    Mari, Daniela
    Busacca, Mauro
    Vercellini, Paolo
    Somigliana, Edgardo
    di Blasio, Anna Maria
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2009, 146 (02) : 219 - 221
  • [8] Plasminogen activator inhibitor-1 promoter 4G/5G genotype is not a risk factor for myocardial infarction in a Japanese population
    Sugano, T
    Tsuji, H
    Masuda, H
    Nakagawa, K
    Nishimura, H
    Kasahara, T
    Yoshizumi, M
    Nakahara, Y
    Kitamura, H
    Yamada, K
    Yoneda, M
    Maki, K
    Tatsumi, T
    Azuma, A
    Nakagawa, M
    BLOOD COAGULATION & FIBRINOLYSIS, 1998, 9 (02) : 201 - 204
  • [9] Plasminogen activator inhibitor-1 4G/5G polymorphism in infertile women with and without endometriosis
    Goncalves-Filho, Rubens P.
    Brandes, Ariel
    Christofolini, Denise M.
    Lerner, Tatiana G.
    Bianco, Bianca
    Barbosa, Caio P.
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2011, 90 (05) : 473 - 477
  • [10] The common -675 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene is strongly associated with obesity
    Hoffstedt, J
    Andersson, LL
    Persson, L
    Isaksson, B
    Arner, P
    DIABETOLOGIA, 2002, 45 (04) : 584 - 587